Evidence map›Paper›PMID 35173104›Full record

ArticleNeurologia medico-chirurgica2022

Perioperative Deep Vein Thrombosis and D-dimer Measurement in Patients with Brain Tumor.

Emiko Okamoto, Eiichi Ishikawa, Hiroyoshi Kino, Hidehiro Kohzuki, Narushi Sugii, Hiroyuki Naito, Takuma Hara, Satoshi Homma, Masahide Matsuda, Takao Tsurubuchi and 3 more

Abstract read
In one paragraph

Article in Neurologia medico-chirurgica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Emiko OkamotoGraduate School of Comprehensive Human Sciences, University of Tsukuba.
Eiichi IshikawaDepartment of Neurosurgery, Faculty of Medicine, University of Tsukuba.
Hiroyoshi KinoDepartment of Neurosurgery, Faculty of Medicine, University of Tsukuba.
Hidehiro KohzukiDepartment of Neurosurgery, Faculty of Medicine, University of Tsukuba.
Narushi SugiiDepartment of Neurosurgery, Faculty of Medicine, University of Tsukuba.
Hiroyuki NaitoClinical Laboratory, University of Tsukuba Hospital.
Takuma HaraDepartment of Neurosurgery, Faculty of Medicine, University of Tsukuba.
Satoshi HommaDepartment of Cardiology, Faculty of Medicine, University of Tsukuba.
Masahide MatsudaDepartment of Neurosurgery, Faculty of Medicine, University of Tsukuba.
Takao TsurubuchiDepartment of Neurosurgery, Faculty of Medicine, University of Tsukuba.
Takaaki IshikawaDepartment of Neurosurgery, Faculty of Medicine, University of Tsukuba.
Yasushi KawakamiDepartment of Clinical Laboratory Medicine, Faculty of Medicine, University of Tsukuba.
Hiroyoshi AkutsuDepartment of Neurosurgery, Faculty of Medicine, University of Tsukuba.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated the appropriate D-dimer cutoff value for each brain tumor type for acute or subacute deep vein thrombosis (DVT) following transcranial brain tumor surgery.In this single-center retrospective study, a cumulative total of 128 patients who underwent transcranial brain tumor surgery were enrolled and classified into the glioma group, the other intracranial malignant tumor group, and the intracranial benign tumor group. Venous ultrasonography was performed if the D-dimer plasma levels were positive (≥1 μg/mL) before surgery and on postoperative day (POD) 3 or 7.Of the 128 cases, DVT developed in 32 (25.0%). Among those, acute or subacute DVT was diagnosed in 22 cases on POD 3 and in 8 cases on POD 7. Compared with DVT-negative cases on POD 3, acute or subacute DVT-positive cases on POD 3 revealed a significant increase in the D-dimer level in all groups combined and in the benign tumor group but not in the glioma group. With regard to DVT on POD 3 in all groups, the receiver operating characteristic curve for the D-dimer level on POD 3 demonstrated a cutoff value of 3.3 μg/mL (sensitivity [0.636] and specificity [0.750]). However, if this cutoff value was used in practice, eight cases would be false-negative with a minimum D-dimer level of 1.5 μg/mL.The D-dimer cutoff value for acute or subacute DVT on POD 3 could be set to 3.3 μg/mL; however, the setting resulted in several false-negative cases. Practically, 1.5 μg/mL of the D-dimer cutoff value on POD 3 might be appropriate to avoid false-negative results.

Indexed as

Brain NeoplasmsGliomaVenous ThrombosisFibrin Fibrinogen Degradation ProductsHumansPredictive Value of TestsRetrospective StudiesFibrin Fibrinogen Degradation Productsfibrin fragment Dbrain tumor surgerycomplicationD-dimerdeep vein thrombosisglioma

Identifiers

PMID35173104
PMCPMC9093672

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.